Search
for
Sort by
Research 30 of 1000+
- Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns
- Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review
- Hair Loss Associated With IL ‐17 and IL ‐23 Inhibitors: A Systematic Review
- 0413 IL-17 Inhibitors vs. methotrexate in preventing new-onset psoriatic arthritis in psoriasis patients: a retrospective population-level analysis
- 0248 Risk of infections in patients with hidradenitis suppurativa treated with TNF-α inhibitors vs. IL-17 inhibitors: A large-scale cohort study
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Hidradenitis suppurativa secondary to treatment with a gamma secretase inhibitor
- Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Novel investigational drugs for alopecia areata and future perspectives
- 224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Psoriasis and Alopecia: Unveiling the Links
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib